Literature DB >> 19061929

Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems.

Jan Bonhoeffer1, Adwoa Bentsi-Enchill, Robert T Chen, Margaret C Fisher, Michael S Gold, Katharina Hartman, Ulrich Heininger, Bernard Hoet, Thomas Jefferson, Najwa Khuri-Bulos, Katrin Kohl, S Michael Marcy, David Nalin, Robert Pless, Hernan Sanabria-Rojas, Karen Sleeman, Robert Wise.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19061929     DOI： 10.1016/j.vaccine.2008.11.035

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  8 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background.

Authors:  Susanna Esposito; Elisabetta Prada; Maria Vincenza Mastrolia; Giusyda Tarantino; Claudio Codecà; Donato Rigante
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.

Authors:  Flor M Munoz; Leonard E Weisman; Jennifer S Read; George Siberry; Karen Kotloff; Jennifer Friedman; Rosemary D Higgins; Heather Hill; Harry Seifert; Mirjana Nesin
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

3.  Reporting of adverse events following immunizations in Ghana - Using disproportionality analysis reporting ratios.

Authors:  Daniel N A Ankrah; Delese M Darko; George Sabblah; Aukje Mantel-Teeuwisse; Hubert M G Leufkens
Journal:  Hum Vaccin Immunother       Date:  2017-11-27       Impact factor: 3.452

4.  A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).

Authors:  Roman Prymula; Susanna Esposito; Gian Vincenzo Zuccotti; Fang Xie; Daniela Toneatto; Igor Kohl; Peter M Dull
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.

Authors:  Susan L Hills; Sann Chan Soeung; Svay Sarath; Chheng Morn; Cheam Dara; Marc Fischer; Michael C Thigpen
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

6.  Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control.

Authors:  Hextan Y S Ngan; Suzanne M Garland; Neerja Bhatla; Sonia R Pagliusi; Karen K L Chan; Annie N Y Cheung; Tang-Yuan Chu; Efren J Domingo; You Lin Qiao; Jong Sup Park; Eng Hseon Tay; Wisit Supakarapongkul
Journal:  J Cancer Epidemiol       Date:  2011-04-13

7.  Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.

Authors:  Benjamin Mordmüller; Christian Supan; Kim Lee Sim; Gloria P Gómez-Pérez; Carmen Lucelly Ospina Salazar; Jana Held; Stefanie Bolte; Meral Esen; Serena Tschan; Fanny Joanny; Carlos Lamsfus Calle; Sascha J Z Löhr; Albert Lalremruata; Anusha Gunasekera; Eric R James; Peter F Billingsley; Adam Richman; Sumana Chakravarty; Almudena Legarda; Jose Muñoz; Rosa M Antonijoan; Maria Rosa Ballester; Stephen L Hoffman; Pedro L Alonso; Peter G Kremsner
Journal:  Malar J       Date:  2015-03-18       Impact factor: 2.979

8.  The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada.

Authors:  Julie A Bettinger; Manish Sadarangani; Gaston De Serres; Louis Valiquette; Otto G Vanderkooi; James D Kellner; Matthew P Muller; Karina A Top; Jennifer E Isenor; Allison McGeer; Kimberly Marty
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.